Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Acambis Initiates Rolling BLA For Its Cell Culture-Based Smallpox Vaccine

This article was originally published in The Pink Sheet Daily

Executive Summary

The firm said it expects to complete the filing by April and receive approval by year-end.

You may also be interested in...



Acambis’ Smallpox Vaccine Could See Approval As Soon As First Half 2007

An FDA “complete response” letter for the cell-based vaccine cites both clinical and CMC sections of the BLA, firm tells “The Pink Sheet” DAILY.

Acambis’ Smallpox Vaccine Could See Approval As Soon As First Half 2007

An FDA “complete response” letter for the cell-based vaccine cites both clinical and CMC sections of the BLA, firm tells “The Pink Sheet” DAILY.

Acambis Completes Smallpox Vaccine BLA

Acambis' ACAM2000 would have a mid-October estimated user fee date if the BLA is granted a priority review

Related Content

Topics

UsernamePublicRestriction

Register

LL1129949

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel